Patients with sickle cell anemia vary in the hematologic and clinical features of their disease, in part because of variability in the presence of linked and unlinked genes that modify the expression of the disease. The hemoglobin S gene is strongly linked to three different haplotypes of polymorphic endonuclease-restriction sites of the beta-like gene cluster (genes in the vicinity of the beta-globin gene)--one prevalent in Atlantic West Africa, another in central West Africa, and yet another in Bantu-speaking Africa (equatorial, East, and southern Africa). We have studied the differences in the hematologic characteristics of patients with sickle cell anemia from the first two geographical areas. We find that the Senegalese (Atlantic West Africa) patients have higher levels of hemoglobin F, a preponderance of G gamma chains in hemoglobin F, a lower proportion of very dense red cells, and a lower percentage of irreversibly sickled cells than those from Benin (central West Africa). We interpret these data to mean that the gamma-chain composition and the hemoglobin F level are haplotype linked and that the decrease in the percentage of dense cells and irreversibly sickled cells is secondary to the elevation in the hemoglobin F level. Patients with sickle cell anemia in the New World probably correspond to various combinations of these types, in addition to the still hematologically undefined haplotype associated with sickle cell anemia in the Bantu-speaking areas of Africa.
This article has been cited by other articles:
Modiano, D., Bancone, G., Ciminelli, B. M., Pompei, F., Blot, I., Simpore, J., Modiano, G.
(2008). Haemoglobin S and haemoglobin C: 'quick but costly' versus 'slow but gratis' genetic adaptations to Plasmodium falciparum malaria. Hum Mol Genet
17: 789-799
[Abstract][Full Text]
Guo, Z., Hood, L., Malkki, M., Petersdorf, E. W.
(2006). Long-range multilocus haplotype phasing of the MHC. Proc. Natl. Acad. Sci. USA
103: 6964-6969
[Abstract][Full Text]
Driscoll, M. C., Hurlet, A., Styles, L., McKie, V., Files, B., Olivieri, N., Pegelow, C., Berman, B., Drachtman, R., Patel, K., Brambilla, D.
(2003). Stroke risk in siblings with sickle cell anemia. Blood
101: 2401-2404
[Abstract][Full Text]
GUASCH, A., ZAYAS, C. F., ECKMAN, J. R., MURALIDHARAN, K., ZHANG, W., ELSAS, L. J.
(1999). Evidence that Microdeletions in the {alpha} Globin Gene Protect Against the Development of Sickle Cell Glomerulopathy in Humans. J. Am. Soc. Nephrol.
10: 1014-1019
[Abstract][Full Text]
McMahon, L. E.C., Mark, E. J.
(1997). Case 34-1997- A 22-Year-Old Man with a Sickle Cell Crisis and Sudden Death. NEJM
337: 1293-1301
[Full Text]
Steinberg, M. H., Lu, Z.-H., Barton, F. B., Terrin, M. L., Charache, S., Dover, G. J., the Multicenter Study of Hydroxyurea,
(1997). Fetal Hemoglobin in Sickle Cell Anemia: Determinants of Response to Hydroxyurea. Blood
89: 1078-1088
[Abstract][Full Text]
Rogers, Z. R., Powars, D. R., Kinney, T. R., Williams, W. D., Schroeder, W. A.
(1989). Nonblack Patients With Sickle Cell Disease Have African {beta}s Gene Cluster Haplotypes. JAMA
261: 2991-2994
[Abstract]
Benjamin, J. T., Gootenberg, J. E.
(1987). Severe Manifestations of Sickle Cell Anemia in a White American Child. CLIN PEDIATR
26: 648-650
Scott, R. B.
(1985). Advances in the Treatment of Sickle Cell Disease in Children. Arch Pediatr Adolesc Med
139: 1219-1222
[Abstract]
Johnson, C. S.
(1985). Sickle Cell Anemia. JAMA
254: 1958-1963
[Abstract]
Lee, J.-S., Ngo, H., Kim, D., Chung, J. H.
(2000). Erythroid Kruppel-like factor is recruited to the CACCC box in the beta -globin promoter but not to the CACCC box in the gamma -globin promoter: The role of the neighboring promoter elements. Proc. Natl. Acad. Sci. USA
97: 2468-2473
[Abstract][Full Text]